124 related articles for article (PubMed ID: 12153744)
1. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility.
van Santbrink EJ; Eijkemans MJ; Macklon NS; Fauser BC
Eur J Endocrinol; 2002 Aug; 147(2):223-6. PubMed ID: 12153744
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.
Imani B; Eijkemans MJ; Faessen GH; Bouchard P; Giudice LC; Fauser BC
Fertil Steril; 2002 Jan; 77(1):83-90. PubMed ID: 11779595
[TBL] [Abstract][Full Text] [Related]
3. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
van Santbrink EJ; Fauser BC
J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
[TBL] [Abstract][Full Text] [Related]
4. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
5. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2361-5. PubMed ID: 9661609
[TBL] [Abstract][Full Text] [Related]
6. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate.
Nyboe Andersen A; Balen A; Platteau P; Devroey P; Helmgaard L; Arce JC;
Hum Reprod; 2008 Jun; 23(6):1424-30. PubMed ID: 18372254
[TBL] [Abstract][Full Text] [Related]
7. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
Fertil Steril; 2002 Jan; 77(1):91-7. PubMed ID: 11779596
[TBL] [Abstract][Full Text] [Related]
8. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2).
Eijkemans MJ; Imani B; Mulders AG; Habbema JD; Fauser BC
Hum Reprod; 2003 Nov; 18(11):2357-62. PubMed ID: 14585887
[TBL] [Abstract][Full Text] [Related]
9. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
[TBL] [Abstract][Full Text] [Related]
10. Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility.
Valkenburg O; van Santbrink EJ; König TE; Themmen AP; Uitterlinden AG; Fauser BC; Lambalk CB; Laven JS
Fertil Steril; 2015 Apr; 103(4):1081-1088.e3. PubMed ID: 25721191
[TBL] [Abstract][Full Text] [Related]
11. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility.
Mulders AG; Eijkemans MJ; Imani B; Fauser BC
Reprod Biomed Online; 2003 Sep; 7(2):170-8. PubMed ID: 14567885
[TBL] [Abstract][Full Text] [Related]
12. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
Coelingh Bennink HJ; Fauser BC; Out HJ
Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Eijkemans MJ; Habbema JD; Fauser BC
Semin Reprod Med; 2003 Feb; 21(1):39-47. PubMed ID: 12806558
[TBL] [Abstract][Full Text] [Related]
14. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
Ho Yuen B; Pride SM; Sime MO
Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
[TBL] [Abstract][Full Text] [Related]
15. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
[TBL] [Abstract][Full Text] [Related]
17. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
18. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
Yarali H; Bukulmez O; Gurgan T
Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
Balasch J; Fábregues F; Creus M; Casamitjana R; Puerto B; Vanrell JA
J Assist Reprod Genet; 2000 Nov; 17(10):561-5. PubMed ID: 11209536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
